InvestorsHub Logo
Followers 36
Posts 3655
Boards Moderated 0
Alias Born 07/08/2002

Re: $5.95akadawson-m post# 219906

Wednesday, 05/03/2023 11:19:19 PM

Wednesday, May 03, 2023 11:19:19 PM

Post# of 232267
IT CAN'T BE TRUE! Check out the bio on Dr. Scott Hansen:

Dr. Hansen’s research laboratory has been studying leronlimab since the Spring of 2021. In this time he has developed numerous flow cytometry biomarker assays to investigate how leronlimab/CCR5 modulates various immune cell phenotypes. Additionally, he developed an exploratory CCR5 receptor occupancy assay to evaluate leronlimab binding/loading after dosing. Dr. Hansen’s work has led to two research publications (one pending publication) that has already furthered CytoDyn’s understanding on the mechanism of action and potential applications of leronlimab in NASH and oncology.

SINCE 2021!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News